National Cancer Prevention and Control Program; Notice of Availability of Open Season Funds, 2407-2410 [05-488]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 9 / Thursday, January 13, 2005 / Notices
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than February 7, 2005.
A. Federal Reserve Bank of New
York (Jay Bernstein, Bank Supervision
Officer) 33 Liberty Street, New York,
New York 10045–0001:
1. First BanCorp, San Juan, Puerto
Rico; to acquire 100 percent of the
voting shares of Ponce General
Corporation, San Juan, Puerto Rico, and
thereby indirectly acquire UniBank,
Miami, Florida, and thereby engage in
operating a savings association pursuant
to section 225.28(b)(4) of Regulation Y.
Board of Governors of the Federal Reserve
System, January 7, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–677 Filed 1–12–05; 8:45 am]
BILLING CODE 6210–01–S
OFFICE OF GOVERNMENT ETHICS
Study Evaluating, and Making
Recommendations for Improving, the
Financial Disclosure Process for
Employees of the Executive Branch;
Opportunity for Comment
AGENCY:
Office of Government Ethics
(OGE).
ACTION:
Notice.
SUMMARY: The Office of Government
Ethics is conducting a study, pursuant
to the Intelligence Reform and
Terrorism Prevention Act of 2004, to
evaluate and recommend improvements
to the public financial disclosure
process for employees of the executive
branch. This notice indicates the
pendency of OGE’s study and provides
the public and agencies the opportunity
to comment.
DATES: Any comments from the public
and the agencies must be received by
February 11, 2005.
VerDate jul<14>2003
19:36 Jan 12, 2005
Jkt 205001
You may submit comments
to OGE on the study by any of the
following methods:
• E-mail: usoge@oge.gov. For E-mail
messages, the subject line should
include the following reference:
‘‘Comments Regarding Financial
Disclosure Process Study.’’
• FAX: 202–482–9237.
• Mail, Hand Delivery or Courier:
Office of Government Ethics, Suite 500,
1201 New York Avenue, NW.,
Washington, DC 20005–3917, Attention:
Ira S. Kaye, Associate General Counsel.
FOR FURTHER INFORMATION CONTACT: Ira
S. Kaye, Associate General Counsel,
Office of Government Ethics, telephone:
202–482–9300; TDD: 202–482–9293;
FAX: 202–482–9237.
SUPPLEMENTARY INFORMATION: Section
8403 of the Intelligence Reform and
Terrorism Prevention Act of 2004,
Public Law 108–458 (December 17,
2004), directs the Office of Government
Ethics to provide a report to Congress,
within 90 days, evaluating the financial
disclosure process for employees of the
executive branch, and recommending
improvements to it. In order to comply
with this mandate, OGE has undertaken
a study of this subject. OGE’s report will
focus on whether to recommend
amending the body of information that
is statutorily required to be included on
the Standard Form (SF) 278 Executive
Branch Personnel Public Financial
Disclosure Report, as well as whether to
recommend changes to the public
financial disclosure system itself.
Specifically, OGE will analyze whether
to recommend changing: the number of
asset, income, transaction and liability
valuation categories; the various
reporting time periods; the dollar
thresholds for reporting particular
assets, income, transactions and
liabilities; the requirements to report
most transactions, to identify the type of
income earned, and to report the actual
dollar amounts of particular types of
income; and the level of description and
detail required, particularly on
Schedules C (liabilities and agreements
or arrangements) and D (outside
positions and compensation over
$5,000) of the SF 278 report form.
As part of its consideration of these
important matters, OGE believes it
would be both appropriate and helpful
to give the public and agencies an
opportunity to express their views.
Interested persons may submit
comments to OGE, to be received by
February 11, 2005, regarding any
specific part of the financial disclosure
process study or just to give general
views on the study in order to assist
OGE.
ADDRESSES:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
2407
Approved: January 7, 2005.
Marilyn L. Glynn,
Acting Director, Office of Government Ethics.
[FR Doc. 05–710 Filed 1–12–05; 8:45 am]
BILLING CODE 6345–02–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Program Announcement Open Season
02060–FY05]
National Cancer Prevention and
Control Program; Notice of Availability
of Open Season Funds
LOI Deadline: January 28, 2005.
Application Deadline: February 28,
2005.
A. Purpose
The Centers for Disease Control and
Prevention (CDC) announces the
availability of fiscal year (FY) 2005
funds for an Open Season for the
National Cancer Prevention and Control
Program (NCPCP) cooperative
agreement program previously
announced under Program
Announcement 02060 (Henceforth
referred to as ‘‘PA 02060’’). This
program addresses the ‘‘Healthy People
2010’’ focus area(s) related to cancer.
PA02060 was published in the
Federal Register on April 23, 2002,
Volume 67, Number 78, pages 19932–
19950. Amendment 1 was published
May 23, 2002, Amendment 2 was
published January 2, 2003, and
Amendment 3 was published on
January 20, 2004. Applicants may access
the amended version of PA 02060, along
with this Open Season announcement,
on the CDC Web site, Internet address:
https://www.cdc.gov. Click on
‘‘Funding,’’ then ‘‘Grants and
Cooperative Agreements.’’
Sections A.–F. of original PA 02060
are superceded by the Sections A.–F.
published in this announcement.
The NCPCP will assist States/District
of Columbia/Tribes/Territories in
developing, implementing, maintaining,
enhancing, integrating, and evaluating a
cancer program inclusive of cancer
surveillance, prevention and early
detection programs, and which focuses
on eliminating health disparities. The
purpose of each of the three
programmatic components within the
NCPCP follows.
A.1. National Comprehensive Cancer
Control Programs (NCCCP)
The NCCCP component supports the
planning and implementation of
E:\FR\FM\13JAN1.SGM
13JAN1
2408
Federal Register / Vol. 70, No. 9 / Thursday, January 13, 2005 / Notices
comprehensive cancer control activities.
CDC defines comprehensive cancer
control as an integrated and coordinated
approach to reduce the incidence,
morbidity and mortality of cancer
through prevention, early detection,
treatment, rehabilitation, and palliation.
• Other Requirements
• Evaluation Criteria
Please refer to these specific
component sections in PA 02060, and
amendments for information.
A.2. National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP)
The NBCCEDP component supports
the development of systems to assure
breast and cervical cancer screening for
low income, underserved, and
uninsured women with special
emphasis on reaching those who are
geographically or culturally isolated,
older, or members of racial/ethnic
minorities. Components of the
NBCCEDP include program
management; screening & diagnostic
services, to include case management,
tracking and follow-up; data
management; quality assurance/quality
improvement; evaluation; partnerships;
professional development and
recruitment, to include public
education, outreach and inreach. These
components are carried out at the local,
State and national levels through
collaborative partnerships with State
health agencies, community-based
organizations, tribal governments,
universities, a variety of medical care
providers and related agencies and
institutions, and the business and
voluntary sectors. These partners work
together to develop, implement and
evaluate strategies to promote breast and
cervical cancer prevention and early
detection, to increase access to related
services and to improve the quality and
timeliness of the services.
Conference Call: Technical assistance
will be available for potential applicants
on a conference call that will be held on
January 19, 2005, from 3:30 p.m. to 5:30
p.m. (Eastern time). Potential applicants
are requested to call in using only one
telephone line. The conference can be
accessed by calling 1–888–576–9873,
and entering the passcode 21028.
The purpose of the conference call is
to help potential applicants to:
1. Understand the process for the
Open Season Announcement for PA
02060 for the National Cancer
Prevention and Control Program;
2. Understand the scope and intent of
PA 02060 for the National Cancer
Prevention and Control Program;
3. Be familiar with the Public Health
Services funding policies and
application and review procedures.
Participation in this conference call is
not mandatory. At the time of the call,
if you have problems accessing the
conference call, please call 404–639–
7550.
A.3. National Program of Cancer
Registries (NPCR)
The NPCR component supports efforts
to establish population-based cancer
registries where they do not exist and to
improve existing cancer registries.
PA 02060 and applicable
amendments, contain information that
is specific to the three individual
components. Section G ‘‘Specific
Guidance for NCCCP’’ addresses the
National Comprehensive Cancer Control
Program; Section H ‘‘Specific Guidance
for NCCEDP’’ addresses the National
Breast and Cervical Cancer Early
Detection Program; and Section I
‘‘Specific Guidance for NPCR’’
addresses the National Program of
Cancer Registries. These component
sections include specific guidance
regarding:
• Eligibility
• Program Requirements
• Content
VerDate jul<14>2003
17:46 Jan 12, 2005
Jkt 205001
Special Guidelines for Technical
Assistance
B. Eligible Applicants
Applicants may apply for any or all of
the components within this Open
Season announcement for which they
are eligible and that they are not
currently funded for under PA 02060.
B.1. Eligible for NCCCP
Potential applicants that are eligible
for components of NCCCP are the health
departments of States or their bona fide
agents, the Commonwealth of Puerto
Rico, the Virgin Islands, the
Commonwealth of the Northern Mariana
Islands, American Samoa, Guam, the
Federated States of Micronesia, the
Republic of the Marshall Islands, and
Federally recognized Indian Tribal
governments and Tribal organizations,
urban Indian organizations and intertribal consortia (hereafter referred to as
Tribes) whose primary purpose is to
improve American Indian/Alaska Native
health and which represent the Native
population in their catchment area, that
are not currently funded for NCCCP
under PA 02060.
B.2. Eligible for NBCCEP
Potential applicants that are eligible
for NBCCEDP are the Virgin Islands, the
Commonwealth of the Northern Mariana
Islands, the Federated States of
Micronesia, the Republic of the
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Marshall Islands, and Federally
recognized Indian Tribal governments
and Tribal organizations, urban Indian
organizations and inter-tribal consortia
(hereafter referred to as Tribes) whose
primary purpose is to improve
American Indian/Alaska Native health
and which represent the Native
population in their catchment area, that
are not currently funded for NBCCEDP
under PA 02060.
B.3. Eligible for NPCR
Potential applicants that are eligible
for components of NPCR are the health
departments of States or their bona fide
agents, the Commonwealth of the
Northern Mariana Islands, American
Samoa, Guam, the Federated States of
Micronesia, the Republic of the
Marshall Islands, and academic or
nonprofit organizations designated by a
State to operate the State’s cancer
registry, that are not currently funded
under PA 02060.
Note: Title 2 of the United States Code
section 1611 states that an organization
described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying
activities is not eligible to receive Federal
funds constituting an award, grant or loan.
C. Availability of Funds
Pending availability of FY 2005 funds,
approximately $1,850,000 is available in
FY 2005 to fund new programs under
the Open Season for PA 02060-FY05.
Awards under PA 02060 were made
for a Project Period of September 30,
2002 through June 29, 2007. The first
funding period was for the period
September 30, 2002 through June 29,
2003. The second funding period was
for the period June 30, 2003 through
June 29, 2004. The third funding period
was for the period June 30, 2004
through June 29, 2005. Awards under
this Open Season announcement will be
for the Period of June 30, 2005 through
June 29, 2007, with funding for the
period June 30, 2005 through June 29,
2006. Future budget periods will be 12month periods, and will begin on June
30 of every year and run through June
29 of each following year. These budget
periods will occur until the expiration
of the project period for PA 02060,
which is June 29, 2007.
In Accordance with G.2.d. of PA 2060,
Amendment 4, there will be no funding
preferences applicable to this funding
period.
All new applications will be reviewed
through an Objective Review process.
C.1. Component Funding
NCCCP $250,000
NBCCEDP $0 (No Open Season Funds
Available for FY05)
E:\FR\FM\13JAN1.SGM
13JAN1
Federal Register / Vol. 70, No. 9 / Thursday, January 13, 2005 / Notices
C.4. Recipient Financial Participation
NPCR $250,000
NCCCP—Additional Optional
Funding available for recipients of
NCCCP Implementation Programs as
follows:
Colorectal cancer activities $250,000
Ovarian cancer activities $500,000
Prostate cancer activities $500,000
Skin cancer activities $100,000
For specific ‘‘Recipient Financial
Participation’’ information, please refer
to Sections G, H, and I of PA 02060 and
amendments.
C.5. Direct Assistance
C.2. Requested Budget Information
Applicants should submit separate
budgets for each component (as well as
separate budgets if applying for the
Additional Optional Funding under
NCCCP) in response to this Open
Season announcement. Each detailed
budget and narrative justification
should support the activities for the
funding period specified in this Program
Announcement for FY 2005 support.
Applications should follow the
guidance provided under each program
component in PA 02060 and applicable
amendments, with respect to the
development and submission of an
itemized budget and justification.
C.3. Use of Funds
For specific ‘‘Use of Funds’’
information, refer to Sections G, H, and
I of PA 02060 and amendments.
Cooperative agreement funds may be
used to support personnel and to
purchase equipment, supplies, and
services directly related to project
activities and consistent with the scope
of the cooperative agreement.
Funds provided under this program
announcement may not be used to:
• Conduct research projects.
Guidance regarding CDC’s definition of
‘‘research’’ should be reviewed at http:
//www.cdc.gov/od/ads/opspoll1.htm.
• Supplant State or local funds, to
provide inpatient care or treatment, or
to support the construction or
renovation of facilities.
Applicants are encouraged to identify
and leverage mutually beneficial
opportunities to interact and integrate
with other State health department
programs that address related chronic
diseases or risk factors. This may
include cost sharing to support a shared
position such as a Chronic Disease
Epidemiologist, Health Communication
Specialist, Program Evaluator, or Policy
Analyst to work on relevant activities
across units/departments within the
State health department. Such activities
may include, but are not limited to joint
planning, joint funding of
complementary activities, public health
education, collaborative development
and implementation of environmental,
policy, systems, or community
interventions and other cost sharing
activities.
VerDate jul<14>2003
17:46 Jan 12, 2005
Jkt 205001
For specific ‘‘Direct Assistance’’
information, please refer to Sections G,
H, and I of PA 02060 and amendments.
C.6. Funding Preferences
In accordance with the ‘‘Funding
Preference’’ section of the amended PA
02060, no funding preference will be
given for this period. For specific
‘‘Funding Preference’’ information,
please refer to Sections G, H, and I of
PA 02060 and amendments.
C.7. Funding Consideration
For specific ‘‘Funding Consideration’’
information, please refer to Sections G,
H, and I of PA 02060 and amendments.
D. Content
D.1. Letter of Intent
One Letter of Intent (LOI) is requested
from each applicant applying for any
component(s) of this program. The
narrative should be no more than one
single-spaced page, printed on one side,
with one-inch margins, and unreduced
font. Your LOI will not be evaluated, but
will be used to assist CDC in planning
for the objective review for this program
and should include the announcement
number, the specific component(s) and
parts of the component, if applicable,
for which funds are being applied, and
the name of the principal investigator.
D.2. Application Development
Please refer to Sections G, H, and I of
PA 02060 and amendments to use the
information in the Program
Requirements, Other Requirements, and
Evaluation Criteria sections to develop
the application content. Your
application will be evaluated using the
criteria listed, so it is important to
follow them in laying out your
application.
Applications should follow the
guidance below with respect to page
limitations for each component. All
applications should be printed on one
side, with one-inch margins, using
unreduced font. All materials must be
provided in an unbound, one-sided, 81⁄2
x 11″ print format, suitable for
photocopying (i.e., no audiovisual
materials, posters, tapes, etc.).
D.3. Page Limitations
For specific ‘‘Page Limitations’’
information, please see Sections G, H,
and I of PA 02060 and amendments.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
2409
D.4. Application Outline
Applicants may apply for any or all of
the components within this program
announcement for which they are
eligible. Please provide specific
‘‘Application Outline’’ information for
each component as outlined in specific
Sections G, H, and I of PA 02060 and
amendments.
E. Submission and Deadline
E1. Letter of Intent
On or before January 28, 2004, submit
the LOI to the National Center for
Chronic Disease Prevention and Control.
By mail: Tanya Hicks, Program
Analyst, CDC National Center for
Chronic Disease Prevention and Health
Promotion, 4770 Buford Hwy, NE, MS
K–57, Atlanta, GA 30341–3717; or by
courier service: Tanya Hicks, Koger
Center, 2858 Woodcock Blvd, Davidson
Bldg, Room 2081, Chamblee, GA 30341;
or by fax: 770–488–3230; or by e-mail:
Thicks@cdc.gov.
E.2. Application
Submit the original and two copies of
CDC Form 0.1246. Forms are available
in the application kit and at the
following Internet address:
www.cdc.gov/od/pgo/forminfo.htm.
On or before February 28, 2005,
submit the original and two copies of
the application to: Technical
Information Management—
PA02060FY05, Procurement and Grants
Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road,
Atlanta, GA 30341–4146.
Applications may not be submitted
electronically at this time.
Please reference Program
Announcement Number 02060–FY05
National Cancer Prevention and Control
Program on the mailing envelope and on
the application Standard Form 424,
block 11. Please also make sure that
block 16 on Standard Form 424
regarding Executive Order 12372 has
been completed correctly.
E.3. Deadline
Applications must be received in the
CDC Procurement and Grants Office by
4 p.m. Eastern time on the deadline
date. If you send your application by the
United States Postal Service of
commercial delivery service, you must
ensure that the carrier will be able to
guarantee delivery of the application by
the closing date and time. If CDC
receives your application after closing
due to: (1) Carrier error, when the
carrier accepted the package with a
guarantee for delivery by the closing
date and time, or (2) significant weather
delays or natural disasters, you will be
E:\FR\FM\13JAN1.SGM
13JAN1
2410
Federal Register / Vol. 70, No. 9 / Thursday, January 13, 2005 / Notices
given the opportunity to submit
documentation of the carriers guarantee.
If the documentation verifies a carrier
problem, CDC will consider the
application as having been received by
the deadline.
CDC will not notify you upon receipt
of your application. If you have a
question about the receipt of your
application, first contact your courier. If
you still have a question, contact the
PGO–TIM staff at: 770–488–2700. Before
calling, please wait two to three days
after the application deadline. This will
allow time for the applications to be
processed and logged.
F. Evaluation Criteria
Each application will be evaluated
individually will be reviewed through
an Objective Review process.
For specific ‘‘Evaluation Criteria’’
information, please see Sections G, H,
and I of PA 02060 and amendments.
G. Where To Obtain Additional
Information
This and other CDC announcements
can be found on the CDC home page
Internet address—https://www.cdc.gov.
Click on ‘‘Funding’’ then ‘‘Grants and
Cooperative Agreements.’’
If you have questions after reviewing
the contents of all the documents,
business management technical
assistance in the states may be obtained
from: Annie Camacho or Glynnis
Taylor, Grants Management Specialist,
CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA
30341–4146, Telephone number: Annie
Camacho: 770–488–2735, Glynnis
Taylor: 770–488–2752, E-mail address:
Annie Camacho: atc4@cdc.gov, Glynnis
Taylor: gld1@cdc.gov.
Business management technical
assistance in the territories may be
obtained from: Vincent Falzone, Grants
Management Specialist, CDC
Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341–
4146, Telephone number: 770–488–
2763, E-mail address: vcf6@cdc.gov.
For program technical assistance
contact:
NCCCP: Leslie S. Given, M.P.A.,
Public Health Advisor, NCCCP, Program
Services Branch, Division of Cancer
Prevention and Control, National Center
for Chronic Disease Prevention and
Health Promotion, Centers for Disease
Control and Prevention, 4770 Buford
Hwy., NE (MS K–57), Atlanta, GA
30341–3717, Telephone number: 770–
488–3099, E-mail address: llg5@cdc.gov.
NBCCEDP: Susan True, M.Ed., Branch
Chief, Program Services Branch,
Division of Cancer Prevention and
VerDate jul<14>2003
17:46 Jan 12, 2005
Jkt 205001
Control, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Hwy., NE
(MS K–57), Atlanta, GA 30341–3717,
Telephone number: 770–488–4880, Email address: smt7@cdc.gov.
NPCR: Lois Voelker, Public Health
Advisor, Cancer Surveillance Branch,
Division of Cancer Prevention and
Control, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Hwy., NE
(MS K–53), Atlanta, GA 30341–3717,
Telephone number: 770–488–3095, Email address: lvoelker@cdc.gov.
Dated: January 5, 2005.
William P. Nichols,
Acting Director, Procurement and Grants
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–488 Filed 1–12–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Fourth National Incidence
Study of Child Abuse and Neglect.
OMB No.: 0970–0276.
Description: The Department of
Health and Human Services (HHS)
intends to issue letters to recruit
agencies for participation in the next
National Incidence Study of Child
Abuse and Neglect (NIS). This will be
the fourth cycle of this periodic study.
NIS–1, mandated under Public Law
(Pub. L.) 93–247 (1974), was conducted
in 1979 and 1980 and reported in 1981.
NIS–2 was mandated under Pub. L. 98–
457 (1984), conducted in 1986 and 1987
and reported in 1988. NIS–3 was
mandated under both the Child Abuse
Prevention, Adoption, and Family
Services Act of 1988 (Pub. L. 100–294)
and the Child Abuse, Domestic
Violence, Adoption and Family Services
Act of 1992 (Pub. L. 102–295), was
conducted between 1993 and 1995 and
published in 1996. NIS–4, mandated by
the Keeping Children and Families Safe
Act of 2003 (Pub. L. 108–36), will be
reported in 2006.
NIS is unique in that it goes beyond
the abused and neglected children who
come to the attention of the Child
Protective Services (CPS) system. In
contrast to the National Child Abuse
and Neglect Data Systems (NCANDS),
which rely solely on reported cases, the
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
NIS design assumes that reported
children represent only a portion of the
children who actually are maltreated.
Following the implications of its
assumptions, NIS estimates the scope of
the maltreated child population by
combining information about reported
cases with data on maltreated children
identified by professionals (called
‘‘sentinels’’) who encounter them during
the normal course of their work in a
wide range of agencies in representative
communities. Sentinels are asked to
remain on the lookout for children they
believe are maltreated during the study
reference period and to provide
information about those children.
Children identified by sentinels and
those whose alleged maltreatment is
investigated by CPS during the same
period are evaluated against
standardized definitions, and only
children who meet the study standards
are used to develop the study estimates.
The study estimates are couched in
terms of numbers of maltreated
children, with data unduplicated so a
given child is counted only once.
Confidentiality of all participants is
carefully protected.
A nationally representative sample of
120 counties will be selected and all
local CPS agencies serving the selected
counties will be identified. Plans will be
developed to obtain data on cases
investigated during the study reference
period, September 4 to December 3,
2005. Sentinels in the selected counties
will be identified through samples of
agencies in 11 categories: county
juvenile probation departments, sheriff
(and/or state police) departments,
public health departments, public
housing departments, municipal police
departments, hospitals, schools, day
care centers, social service agencies,
mental health agencies, and shelters for
battered women or runaway/homeless
youth. A total of approximately 1,600
sentinel agencies will be sampled. Plans
will be developed to identify staff in
these agencies who have direct contact
with children to serve as sentinels
during the study by submitting data on
maltreated children they encounter
during the study reference period. In
preparation for the study, letters will be
sent to the directors of the selected
agencies asking them to permit their
agencies to participate in NIS–4, and
describing the general nature of the data
collection effort. HHS will issue a
subsequent notice of proposed data
collection for this study after data
collection plans are developed.
Respondents: National CPS Agencies
and National Sentinel Agencies.
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 70, Number 9 (Thursday, January 13, 2005)]
[Notices]
[Pages 2407-2410]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-488]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement Open Season 02060-FY05]
National Cancer Prevention and Control Program; Notice of
Availability of Open Season Funds
LOI Deadline: January 28, 2005.
Application Deadline: February 28, 2005.
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2005 funds for an Open Season for the
National Cancer Prevention and Control Program (NCPCP) cooperative
agreement program previously announced under Program Announcement 02060
(Henceforth referred to as ``PA 02060''). This program addresses the
``Healthy People 2010'' focus area(s) related to cancer.
PA02060 was published in the Federal Register on April 23, 2002,
Volume 67, Number 78, pages 19932-19950. Amendment 1 was published May
23, 2002, Amendment 2 was published January 2, 2003, and Amendment 3
was published on January 20, 2004. Applicants may access the amended
version of PA 02060, along with this Open Season announcement, on the
CDC Web site, Internet address: https://www.cdc.gov. Click on
``Funding,'' then ``Grants and Cooperative Agreements.''
Sections A.-F. of original PA 02060 are superceded by the Sections
A.-F. published in this announcement.
The NCPCP will assist States/District of Columbia/Tribes/
Territories in developing, implementing, maintaining, enhancing,
integrating, and evaluating a cancer program inclusive of cancer
surveillance, prevention and early detection programs, and which
focuses on eliminating health disparities. The purpose of each of the
three programmatic components within the NCPCP follows.
A.1. National Comprehensive Cancer Control Programs (NCCCP)
The NCCCP component supports the planning and implementation of
[[Page 2408]]
comprehensive cancer control activities. CDC defines comprehensive
cancer control as an integrated and coordinated approach to reduce the
incidence, morbidity and mortality of cancer through prevention, early
detection, treatment, rehabilitation, and palliation.
A.2. National Breast and Cervical Cancer Early Detection Program
(NBCCEDP)
The NBCCEDP component supports the development of systems to assure
breast and cervical cancer screening for low income, underserved, and
uninsured women with special emphasis on reaching those who are
geographically or culturally isolated, older, or members of racial/
ethnic minorities. Components of the NBCCEDP include program
management; screening & diagnostic services, to include case
management, tracking and follow-up; data management; quality assurance/
quality improvement; evaluation; partnerships; professional development
and recruitment, to include public education, outreach and inreach.
These components are carried out at the local, State and national
levels through collaborative partnerships with State health agencies,
community-based organizations, tribal governments, universities, a
variety of medical care providers and related agencies and
institutions, and the business and voluntary sectors. These partners
work together to develop, implement and evaluate strategies to promote
breast and cervical cancer prevention and early detection, to increase
access to related services and to improve the quality and timeliness of
the services.
A.3. National Program of Cancer Registries (NPCR)
The NPCR component supports efforts to establish population-based
cancer registries where they do not exist and to improve existing
cancer registries.
PA 02060 and applicable amendments, contain information that is
specific to the three individual components. Section G ``Specific
Guidance for NCCCP'' addresses the National Comprehensive Cancer
Control Program; Section H ``Specific Guidance for NCCEDP'' addresses
the National Breast and Cervical Cancer Early Detection Program; and
Section I ``Specific Guidance for NPCR'' addresses the National Program
of Cancer Registries. These component sections include specific
guidance regarding:
Eligibility
Program Requirements
Content
Other Requirements
Evaluation Criteria
Please refer to these specific component sections in PA 02060, and
amendments for information.
Special Guidelines for Technical Assistance
Conference Call: Technical assistance will be available for
potential applicants on a conference call that will be held on January
19, 2005, from 3:30 p.m. to 5:30 p.m. (Eastern time). Potential
applicants are requested to call in using only one telephone line. The
conference can be accessed by calling 1-888-576-9873, and entering the
passcode 21028.
The purpose of the conference call is to help potential applicants
to:
1. Understand the process for the Open Season Announcement for PA
02060 for the National Cancer Prevention and Control Program;
2. Understand the scope and intent of PA 02060 for the National
Cancer Prevention and Control Program;
3. Be familiar with the Public Health Services funding policies and
application and review procedures.
Participation in this conference call is not mandatory. At the time
of the call, if you have problems accessing the conference call, please
call 404-639-7550.
B. Eligible Applicants
Applicants may apply for any or all of the components within this
Open Season announcement for which they are eligible and that they are
not currently funded for under PA 02060.
B.1. Eligible for NCCCP
Potential applicants that are eligible for components of NCCCP are
the health departments of States or their bona fide agents, the
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of
the Northern Mariana Islands, American Samoa, Guam, the Federated
States of Micronesia, the Republic of the Marshall Islands, and
Federally recognized Indian Tribal governments and Tribal
organizations, urban Indian organizations and inter-tribal consortia
(hereafter referred to as Tribes) whose primary purpose is to improve
American Indian/Alaska Native health and which represent the Native
population in their catchment area, that are not currently funded for
NCCCP under PA 02060.
B.2. Eligible for NBCCEP
Potential applicants that are eligible for NBCCEDP are the Virgin
Islands, the Commonwealth of the Northern Mariana Islands, the
Federated States of Micronesia, the Republic of the Marshall Islands,
and Federally recognized Indian Tribal governments and Tribal
organizations, urban Indian organizations and inter-tribal consortia
(hereafter referred to as Tribes) whose primary purpose is to improve
American Indian/Alaska Native health and which represent the Native
population in their catchment area, that are not currently funded for
NBCCEDP under PA 02060.
B.3. Eligible for NPCR
Potential applicants that are eligible for components of NPCR are
the health departments of States or their bona fide agents, the
Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the
Federated States of Micronesia, the Republic of the Marshall Islands,
and academic or nonprofit organizations designated by a State to
operate the State's cancer registry, that are not currently funded
under PA 02060.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant or loan.
C. Availability of Funds
Pending availability of FY 2005 funds, approximately $1,850,000 is
available in FY 2005 to fund new programs under the Open Season for PA
02060-FY05.
Awards under PA 02060 were made for a Project Period of September
30, 2002 through June 29, 2007. The first funding period was for the
period September 30, 2002 through June 29, 2003. The second funding
period was for the period June 30, 2003 through June 29, 2004. The
third funding period was for the period June 30, 2004 through June 29,
2005. Awards under this Open Season announcement will be for the Period
of June 30, 2005 through June 29, 2007, with funding for the period
June 30, 2005 through June 29, 2006. Future budget periods will be 12-
month periods, and will begin on June 30 of every year and run through
June 29 of each following year. These budget periods will occur until
the expiration of the project period for PA 02060, which is June 29,
2007.
In Accordance with G.2.d. of PA 2060, Amendment 4, there will be no
funding preferences applicable to this funding period.
All new applications will be reviewed through an Objective Review
process.
C.1. Component Funding
NCCCP $250,000
NBCCEDP $0 (No Open Season Funds Available for FY05)
[[Page 2409]]
NPCR $250,000
NCCCP--Additional Optional Funding available for recipients of
NCCCP Implementation Programs as follows:
Colorectal cancer activities $250,000
Ovarian cancer activities $500,000
Prostate cancer activities $500,000
Skin cancer activities $100,000
C.2. Requested Budget Information
Applicants should submit separate budgets for each component (as
well as separate budgets if applying for the Additional Optional
Funding under NCCCP) in response to this Open Season announcement. Each
detailed budget and narrative justification should support the
activities for the funding period specified in this Program
Announcement for FY 2005 support.
Applications should follow the guidance provided under each program
component in PA 02060 and applicable amendments, with respect to the
development and submission of an itemized budget and justification.
C.3. Use of Funds
For specific ``Use of Funds'' information, refer to Sections G, H,
and I of PA 02060 and amendments.
Cooperative agreement funds may be used to support personnel and to
purchase equipment, supplies, and services directly related to project
activities and consistent with the scope of the cooperative agreement.
Funds provided under this program announcement may not be used to:
Conduct research projects. Guidance regarding CDC's
definition of ``research'' should be reviewed at http: //www.cdc.gov/
od/ads/opspoll1.htm.
Supplant State or local funds, to provide inpatient care
or treatment, or to support the construction or renovation of
facilities.
Applicants are encouraged to identify and leverage mutually
beneficial opportunities to interact and integrate with other State
health department programs that address related chronic diseases or
risk factors. This may include cost sharing to support a shared
position such as a Chronic Disease Epidemiologist, Health Communication
Specialist, Program Evaluator, or Policy Analyst to work on relevant
activities across units/departments within the State health department.
Such activities may include, but are not limited to joint planning,
joint funding of complementary activities, public health education,
collaborative development and implementation of environmental, policy,
systems, or community interventions and other cost sharing activities.
C.4. Recipient Financial Participation
For specific ``Recipient Financial Participation'' information,
please refer to Sections G, H, and I of PA 02060 and amendments.
C.5. Direct Assistance
For specific ``Direct Assistance'' information, please refer to
Sections G, H, and I of PA 02060 and amendments.
C.6. Funding Preferences
In accordance with the ``Funding Preference'' section of the
amended PA 02060, no funding preference will be given for this period.
For specific ``Funding Preference'' information, please refer to
Sections G, H, and I of PA 02060 and amendments.
C.7. Funding Consideration
For specific ``Funding Consideration'' information, please refer to
Sections G, H, and I of PA 02060 and amendments.
D. Content
D.1. Letter of Intent
One Letter of Intent (LOI) is requested from each applicant
applying for any component(s) of this program. The narrative should be
no more than one single-spaced page, printed on one side, with one-inch
margins, and unreduced font. Your LOI will not be evaluated, but will
be used to assist CDC in planning for the objective review for this
program and should include the announcement number, the specific
component(s) and parts of the component, if applicable, for which funds
are being applied, and the name of the principal investigator.
D.2. Application Development
Please refer to Sections G, H, and I of PA 02060 and amendments to
use the information in the Program Requirements, Other Requirements,
and Evaluation Criteria sections to develop the application content.
Your application will be evaluated using the criteria listed, so it is
important to follow them in laying out your application.
Applications should follow the guidance below with respect to page
limitations for each component. All applications should be printed on
one side, with one-inch margins, using unreduced font. All materials
must be provided in an unbound, one-sided, 8\1/2\ x 11'' print format,
suitable for photocopying (i.e., no audiovisual materials, posters,
tapes, etc.).
D.3. Page Limitations
For specific ``Page Limitations'' information, please see Sections
G, H, and I of PA 02060 and amendments.
D.4. Application Outline
Applicants may apply for any or all of the components within this
program announcement for which they are eligible. Please provide
specific ``Application Outline'' information for each component as
outlined in specific Sections G, H, and I of PA 02060 and amendments.
E. Submission and Deadline
E1. Letter of Intent
On or before January 28, 2004, submit the LOI to the National
Center for Chronic Disease Prevention and Control.
By mail: Tanya Hicks, Program Analyst, CDC National Center for
Chronic Disease Prevention and Health Promotion, 4770 Buford Hwy, NE,
MS K-57, Atlanta, GA 30341-3717; or by courier service: Tanya Hicks,
Koger Center, 2858 Woodcock Blvd, Davidson Bldg, Room 2081, Chamblee,
GA 30341; or by fax: 770-488-3230; or by e-mail: Thicks@cdc.gov.
E.2. Application
Submit the original and two copies of CDC Form 0.1246. Forms are
available in the application kit and at the following Internet address:
www.cdc.gov/od/pgo/forminfo.htm.
On or before February 28, 2005, submit the original and two copies
of the application to: Technical Information Management--PA02060FY05,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Atlanta, GA 30341-4146.
Applications may not be submitted electronically at this time.
Please reference Program Announcement Number 02060-FY05 National
Cancer Prevention and Control Program on the mailing envelope and on
the application Standard Form 424, block 11. Please also make sure that
block 16 on Standard Form 424 regarding Executive Order 12372 has been
completed correctly.
E.3. Deadline
Applications must be received in the CDC Procurement and Grants
Office by 4 p.m. Eastern time on the deadline date. If you send your
application by the United States Postal Service of commercial delivery
service, you must ensure that the carrier will be able to guarantee
delivery of the application by the closing date and time. If CDC
receives your application after closing due to: (1) Carrier error, when
the carrier accepted the package with a guarantee for delivery by the
closing date and time, or (2) significant weather delays or natural
disasters, you will be
[[Page 2410]]
given the opportunity to submit documentation of the carriers
guarantee. If the documentation verifies a carrier problem, CDC will
consider the application as having been received by the deadline.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for the applications to
be processed and logged.
F. Evaluation Criteria
Each application will be evaluated individually will be reviewed
through an Objective Review process.
For specific ``Evaluation Criteria'' information, please see
Sections G, H, and I of PA 02060 and amendments.
G. Where To Obtain Additional Information
This and other CDC announcements can be found on the CDC home page
Internet address--https://www.cdc.gov. Click on ``Funding'' then
``Grants and Cooperative Agreements.''
If you have questions after reviewing the contents of all the
documents, business management technical assistance in the states may
be obtained from: Annie Camacho or Glynnis Taylor, Grants Management
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341-4146, Telephone number: Annie Camacho: 770-488-2735,
Glynnis Taylor: 770-488-2752, E-mail address: Annie Camacho:
atc4@cdc.gov, Glynnis Taylor: gld1@cdc.gov.
Business management technical assistance in the territories may be
obtained from: Vincent Falzone, Grants Management Specialist, CDC
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341-
4146, Telephone number: 770-488-2763, E-mail address: vcf6@cdc.gov.
For program technical assistance contact:
NCCCP: Leslie S. Given, M.P.A., Public Health Advisor, NCCCP,
Program Services Branch, Division of Cancer Prevention and Control,
National Center for Chronic Disease Prevention and Health Promotion,
Centers for Disease Control and Prevention, 4770 Buford Hwy., NE (MS K-
57), Atlanta, GA 30341-3717, Telephone number: 770-488-3099, E-mail
address: llg5@cdc.gov.
NBCCEDP: Susan True, M.Ed., Branch Chief, Program Services Branch,
Division of Cancer Prevention and Control, National Center for Chronic
Disease Prevention and Health Promotion, Centers for Disease Control
and Prevention, 4770 Buford Hwy., NE (MS K-57), Atlanta, GA 30341-3717,
Telephone number: 770-488-4880, E-mail address: smt7@cdc.gov.
NPCR: Lois Voelker, Public Health Advisor, Cancer Surveillance
Branch, Division of Cancer Prevention and Control, National Center for
Chronic Disease Prevention and Health Promotion, Centers for Disease
Control and Prevention, 4770 Buford Hwy., NE (MS K-53), Atlanta, GA
30341-3717, Telephone number: 770-488-3095, E-mail address:
lvoelker@cdc.gov.
Dated: January 5, 2005.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-488 Filed 1-12-05; 8:45 am]
BILLING CODE 4163-18-P
